Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study-Reference-Cited by-同舟云学术

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study

Published:2017-02 Issue:2 Volume:7 Page:e524-e524
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Montillo M,O'Brien S,Tedeschi A,Byrd J C,Dearden C,Gill D,Brown J R,Barrientos J C,Mulligan S P,Furman R R,Cymbalista F,Plascencia C,Chang S,Hsu E,James D F,Hillmen P

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj20175.pdf

Reference15 articles.

1. Hodgson K, Ferrer G, Pereira A, Moreno C, Montserrat E . Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment. Br J Haematol 2011; 154: 14–22.

2. Moreno C, Hodgson K, Ferrer G, Elena M, Filella X, Pereira A et al. Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance. Blood 2010; 116: 4771–4776.

3. Hamblin TJ, Oscier DG, Young BJ . Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 1986; 39: 713–716.

4. Dubovsky JA, Beckwith KA, Natarajan G, Woyach JA, Jaglowski S, Zhong Y et al. Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 2013; 122: 2539–2549.

5. Byrd JC, Brown JR, O'Brien S, Barrientos JC, Kay NE, Reddy NM et al. Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia. N Engl J Med 2014; 371: 213–223.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ibrutinib-induced spinal haematoma in a patient with marginal zone lymphoma;BMJ Case Reports;2024-08

2. Homoeostatic Versus Pathogenic Autoantibodies: Origin, Structure and Effector Functions;Molecular Biology of B Cells;2024

3. The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia—A Review of Current Knowledge;Diagnostics;2023-09-09

4. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia;Journal of Oncology Pharmacy Practice;2023-07-30

5. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias;Leukemia;2023-05-18